Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care

增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产

• 批准号: 10021363
• 金额: $ 31.79万
• 依托单位: ZENTRAXA LIMITED
• 依托单位国家: 英国
• 项目类别: Investment Accelerator
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10021363
• 关键词: Enhanced; bio; production; difficult; make

By 2050, human society is expected to require roughly twice the resources the planet is able to supply to sustain itself. Public awareness of this issue has resulted in an increased demand for sustainable products, and a renewed interest in nature-inspired sustainable alternatives. Biomaterials can be used to provide efficient solutions in a range of areas, creating products that display improved performance and a decreased carbon footprint.However, wide-scale application of biomaterials is historically limited by their costs, difficulties in scaling their production and ethical concerns. Zentraxa's bio-production platform Zentide allows us to ferment specialty biomaterials. Zentide simplifies the production of difficult to make biomaterials allowing us to achieve breakthrough cost economics and scale of production for our materials. This allows us to deliver high-performance biomaterials that meet changing demands and can be easily applied to a range of new markets.Zentraxa have previously developed new types of biological glue for use in skin bonding for medical applications such as dressings & seals. Previous platform development has focused on the production of these adhesive products to deliver use-case demonstrations of specific niche applications. During this project, we aim to improve the production efficiency of our platform and make improvements allowing for production on a larger scale, with greater efficiency and lower cost. We also intend to expand the range of producible materials, and subsequently to apply these to problems in new markets such as personal care (skin creams / hair treatments) and specialty adhesives (for cars and sensor systems). By improving our platform, we ultimately hope to break down the barriers between biotech & new industrial customers, reducing the conventional restrictions of peptides making them and their benefits more accessible & viable for a wealth of new markets.

到2050年，人类社会预计将需要大约两倍于地球能够提供的资源来维持自身。公众对这一问题的认识增加了对可持续产品的需求，并重新对自然启发的可持续替代品产生了兴趣。生物材料可用于在一系列领域提供有效的解决方案，创造出性能更好、碳足迹更低的产品。然而，生物材料的大规模应用历来受到成本、规模生产困难和伦理问题的限制。Zentraxa的生物生产平台Zentide使我们能够发酵特种生物材料。Zentide简化了难以制造的生物材料的生产，使我们能够实现突破性的成本经济和材料生产规模。这使我们能够提供高性能的生物材料，满足不断变化的需求，并可以很容易地应用于一系列新的市场。Zentraxa之前已经开发了用于皮肤粘合的新型生物胶，用于敷料和密封等医疗应用。以前的平台开发集中在这些粘合剂产品的生产上，以提供特定利基应用的用例演示。在这个项目中，我们的目标是提高我们平台的生产效率，并进行改进，以实现更大规模的生产，更高的效率和更低的成本。我们还打算扩大可生产材料的范围，并随后将其应用于新市场的问题，如个人护理（护肤霜/头发护理）和特种粘合剂（用于汽车和传感器系统）。通过改进我们的平台，我们最终希望打破生物技术和新工业客户之间的障碍，减少肽的传统限制，使它们及其益处更容易获得，并在大量新市场中可行。